Immune responses to the ChAdOx1 nCoV-19 and BNT162b2 vaccines and to natural COVID-19 infections over a three-month period.

Ji Yeun KimSo Yun LimSoonju ParkJi-Soo KwonSeongman BaeJi Young ParkHye Hee ChaMi Hyun SeoHyun Jung LeeNakyung LeeKideok KimDavid ShumYoungmee JeeSung Han Kim

Published in: The Journal of infectious diseases (2021)

Antibody responses after the 2 nd dose of BNT162b2 are higher than after the 2 nd dose of ChAdOx1 and like those occurring after natural infection. T cell responses are maintained longer in BNT162b2 vaccinees than in ChAdOx1 vaccinees.

Keyphrases

immune response
coronavirus disease
sars cov
dendritic cells
toll like receptor
respiratory syndrome coronavirus
inflammatory response